Matches in SemOpenAlex for { <https://semopenalex.org/work/W2208689683> ?p ?o ?g. }
- W2208689683 endingPage "1" @default.
- W2208689683 startingPage "1" @default.
- W2208689683 abstract "A pilot study of serotonin-1A receptor genotypes and rapid eye movement sleep sensitivity to serotonergic/cholinergic imbalance in humans: a pharmacological model of depression Kathleen Biard,1,2 Alan B Douglass,2,3 Rébecca Robillard,2 Joseph De Koninck1,2 1School of Psychology, University of Ottawa, 2University of Ottawa Institute for Mental Health Research, 3Royal Ottawa Mental Health Center, University of Ottawa Institute for Mental Health Research, Ottawa, ON, Canada Rationale: The serotonergic and cholinergic systems are jointly involved in regulating sleep but this system is theorized to be disturbed in depressed individuals. We previously reported that cholinergic and serotonergic agents induce sleep changes partially consistent with monoamine models of sleep disturbances in depression. One potential cause of disturbed neurotransmission is genetic predisposition. The G(-1019) allele of the serotonin-1A (5-HT1A) receptor promoter region predicts an increased risk for depression compared to the wild-type C(-1019) allele. Objective: The goal of this study was to investigate how serotonin-1A receptor genotypes mediate sleep sensitivity to pharmacological probes modeling the serotonergic/cholinergic imbalance of depression. Methods: Seventeen healthy female participants homozygous for either C (n=11) or G (n=6) alleles aged 18–27 years were tested on four nonconsecutive nights. Participants were given galantamine (an anti-acetylcholinesterase), buspirone (a serotonergic agonist), both drugs together, or placebos before sleeping. Results: As reported previously, buspirone significantly increased rapid eye movement (REM) latency (P<0.001), as well as awakenings, percentage of time spent awake, and percentage of time asleep spent in stage N1 (P<0.019). Galantamine increased awakenings, percentage of time spent awake, percentage of time asleep spent in stage N1, and percentage of time asleep spent in REM, and decreased REM latency and percentage of time asleep spent in stage N3 (P<0.019). Galantamine plus buspirone given together disrupted sleep more than either drug alone, lowering sleep efficiency and percentage of time asleep spent in stage N3 and increasing awakenings, percentage of time spent awake, and percentage of time asleep spent in stage N1 (P<0.019). There was no main effect of genotype nor was there a significant multivariate interaction between genotype and drug condition. Conclusion: These findings are partially consistent with the literature about sleep in depression, notably short REM latency, higher percentage of total sleep time spent in REM, lower percentage of time asleep spent in stage N3, and increased sleep fragmentation. The C/G mutation in the serotonin-1A receptor promoter region does not appear to cause noticeable differences in the sleep patterns of a relatively small sample of healthy young females. Future studies with larger sample sizes are required. Keywords: depression, sleep, serotonin, acetylcholine, buspirone, galantamine" @default.
- W2208689683 created "2016-06-24" @default.
- W2208689683 creator A5048064488 @default.
- W2208689683 creator A5062708862 @default.
- W2208689683 creator A5078293823 @default.
- W2208689683 creator A5078360660 @default.
- W2208689683 date "2015-12-01" @default.
- W2208689683 modified "2023-09-26" @default.
- W2208689683 title "A pilot study of serotonin-1A receptor genotypes and rapid eye movement sleep sensitivity to serotonergic/cholinergic imbalance in humans: a pharmacological model of depression" @default.
- W2208689683 cites W1471036057 @default.
- W2208689683 cites W1564731682 @default.
- W2208689683 cites W1893119600 @default.
- W2208689683 cites W1964973114 @default.
- W2208689683 cites W1967988092 @default.
- W2208689683 cites W1979153848 @default.
- W2208689683 cites W1988116442 @default.
- W2208689683 cites W2006198196 @default.
- W2208689683 cites W2010764823 @default.
- W2208689683 cites W2013935018 @default.
- W2208689683 cites W2017037741 @default.
- W2208689683 cites W2022024201 @default.
- W2208689683 cites W2023687307 @default.
- W2208689683 cites W2027429673 @default.
- W2208689683 cites W2028827604 @default.
- W2208689683 cites W2031579467 @default.
- W2208689683 cites W2034684273 @default.
- W2208689683 cites W2036783526 @default.
- W2208689683 cites W2041987085 @default.
- W2208689683 cites W2047629955 @default.
- W2208689683 cites W2051846561 @default.
- W2208689683 cites W2056272943 @default.
- W2208689683 cites W2056607297 @default.
- W2208689683 cites W2057346541 @default.
- W2208689683 cites W2103382684 @default.
- W2208689683 cites W2106885532 @default.
- W2208689683 cites W2143683707 @default.
- W2208689683 cites W2161037740 @default.
- W2208689683 cites W2410214125 @default.
- W2208689683 doi "https://doi.org/10.2147/nss.s94549" @default.
- W2208689683 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4690650" @default.
- W2208689683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26719734" @default.
- W2208689683 hasPublicationYear "2015" @default.
- W2208689683 type Work @default.
- W2208689683 sameAs 2208689683 @default.
- W2208689683 citedByCount "2" @default.
- W2208689683 countsByYear W22086896832018 @default.
- W2208689683 countsByYear W22086896832019 @default.
- W2208689683 crossrefType "journal-article" @default.
- W2208689683 hasAuthorship W2208689683A5048064488 @default.
- W2208689683 hasAuthorship W2208689683A5062708862 @default.
- W2208689683 hasAuthorship W2208689683A5078293823 @default.
- W2208689683 hasAuthorship W2208689683A5078360660 @default.
- W2208689683 hasBestOaLocation W22086896831 @default.
- W2208689683 hasConcept C118552586 @default.
- W2208689683 hasConcept C126322002 @default.
- W2208689683 hasConcept C134018914 @default.
- W2208689683 hasConcept C139719470 @default.
- W2208689683 hasConcept C15744967 @default.
- W2208689683 hasConcept C162324750 @default.
- W2208689683 hasConcept C170493617 @default.
- W2208689683 hasConcept C22885893 @default.
- W2208689683 hasConcept C2775864247 @default.
- W2208689683 hasConcept C2776867660 @default.
- W2208689683 hasConcept C2779213384 @default.
- W2208689683 hasConcept C37000724 @default.
- W2208689683 hasConcept C522805319 @default.
- W2208689683 hasConcept C71924100 @default.
- W2208689683 hasConceptScore W2208689683C118552586 @default.
- W2208689683 hasConceptScore W2208689683C126322002 @default.
- W2208689683 hasConceptScore W2208689683C134018914 @default.
- W2208689683 hasConceptScore W2208689683C139719470 @default.
- W2208689683 hasConceptScore W2208689683C15744967 @default.
- W2208689683 hasConceptScore W2208689683C162324750 @default.
- W2208689683 hasConceptScore W2208689683C170493617 @default.
- W2208689683 hasConceptScore W2208689683C22885893 @default.
- W2208689683 hasConceptScore W2208689683C2775864247 @default.
- W2208689683 hasConceptScore W2208689683C2776867660 @default.
- W2208689683 hasConceptScore W2208689683C2779213384 @default.
- W2208689683 hasConceptScore W2208689683C37000724 @default.
- W2208689683 hasConceptScore W2208689683C522805319 @default.
- W2208689683 hasConceptScore W2208689683C71924100 @default.
- W2208689683 hasLocation W22086896831 @default.
- W2208689683 hasLocation W22086896832 @default.
- W2208689683 hasLocation W22086896833 @default.
- W2208689683 hasLocation W22086896834 @default.
- W2208689683 hasOpenAccess W2208689683 @default.
- W2208689683 hasPrimaryLocation W22086896831 @default.
- W2208689683 hasRelatedWork W1984841954 @default.
- W2208689683 hasRelatedWork W1994475532 @default.
- W2208689683 hasRelatedWork W2036082219 @default.
- W2208689683 hasRelatedWork W2050824222 @default.
- W2208689683 hasRelatedWork W2052889702 @default.
- W2208689683 hasRelatedWork W2059229723 @default.
- W2208689683 hasRelatedWork W2087454008 @default.
- W2208689683 hasRelatedWork W2107899720 @default.
- W2208689683 hasRelatedWork W2160769306 @default.
- W2208689683 hasRelatedWork W4241062279 @default.
- W2208689683 isParatext "false" @default.